Latest news with #depressive
Business Upturn
14-05-2025
- Health
- Business Upturn
Neuronetics Launches First Inaugural National TMS Therapy Awareness Day During Mental Health Awareness Month
New national awareness day will foster greater understanding of transcranial magnetic stimulation (TMS) treatment The company will celebrate on social media, sharing patient and provider stories that highlight the impact NeuroStar has as a safe, effective, and non-drug treatment for depression MALVERN, Pa., May 14, 2025 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a vertically integrated, commercial stage, medical technology and healthcare company with a strategic vision of transforming the lives of patients whenever and wherever they need help, with the leading neurohealth therapies in the world, is proud to launch the first National TMS Therapy Awareness Day. The event will take place each year on May 14 during May's Mental Health Awareness Month. This day is dedicated to raising awareness of transcranial magnetic stimulation (TMS) as a proven, non-drug treatment option for individuals living with major depressive disorder (MDD), depression with anxiety, and OCD, especially those who have not found relief through antidepressants. 'National TMS Awareness Day is about giving hope to people who haven't found relief and being a driving force in the National Mental Health Awareness conversation,' said Keith Sullivan, President and Chief Executive Officer of Neuronetics. 'Far too many individuals feel stuck or discouraged after trying multiple antidepressants without receiving adequate relief from their symptoms. By launching this National Day, we want to raise awareness that non-medication approaches like NeuroStar TMS therapy exist—and they're helping real people reclaim their lives. Our goal is to make sure every patient, caregiver, and provider knows that effective, non-drug treatments are available and within reach.' Transcranial magnetic stimulation was first cleared by the FDA in 2008 for treatment-resistant depression in adults. Since then, it has become a widely adopted, evidence-backed modality for those who haven't responded to medication intervention. NeuroStar is the leading TMS therapy in the United States—and in 2024, NeuroStar also received FDA clearance for use in adolescents, expanding access to younger patients in need of non-drug treatment options. Over 300 million people have insurance plans that cover NeuroStar TMS therapy, including Medicare and Tricare. 'One of the reasons NeuroStar is the leading TMS therapy is the precision of our technology,' said Geoffrey Grammer, MD, Chief Medical Officer of Neuronetics. 'Our unique coil design is built to deliver focused magnetic pulses exactly where they're needed. Combined with our Contact Sensing feature, this ensures every session is both consistent and effective, helping patients get the most out of their treatment. We take pride in our scientific and engineering rigor, which continues to advance the field of TMS therapy and enhance the lives of our patients. On National TMS Therapy Awareness Day, we celebrate the real-world impact of NeuroStar TMS Therapy and the difference it makes.' Kristen Gingrich, a licensed clinical social worker, mother, and patient advocate, has documented her experience with NeuroStar TMS after struggling with depression since her teens—worsened by postpartum challenges. After trying talk therapy and multiple antidepressants without lasting relief, she turned to NeuroStar TMS and is now sharing her treatment journey during Mental Health Awareness Month. Kristen's story, which can be seen on both her account (@notyouraveragethrpst) and NeuroStar social media channels, helps shine a light about non-drug options and inspire others facing similar struggles to seek help. In addition to founding this awareness day, NeuroStar TMS continues its legacy as the leading TMS device company by presenting data at the 2025 American Psychiatric Association Annual Meeting (May 17-21). The poster 'The Profile of Symptom Change with Transcranial Magnetic Stimulation for Major Depressive Disorder' builds on prior research and evaluates TMS protocols and their treatment efficacy. To learn more about TMS Awareness Day and NeuroStar TMS therapy, visit About Neuronetics Neuronetics, Inc. believes that mental health is as important as physical health. As a global leader in neuroscience, Neuronetics is delivering more treatment options to patients and physicians by offering exceptional in-office treatments that produce extraordinary results. NeuroStar Advanced Therapy is a non-drug, noninvasive treatment that can improve the quality of life for people suffering from neurohealth conditions when traditional medication has not helped. In addition to selling the NeuroStar Advanced Therapy System and associated treatment sessions to customers, Neuronetics operates Greenbrook TMS Inc. (Greenbrook) treatment centers across the United States, offering NeuroStar Advanced Therapy for the treatment of MDD and other mental health disorders. NeuroStar Advanced Therapy is the leading TMS treatment for MDD in adults, with more than 7.4 million treatments delivered, and is backed by the largest clinical data set of any TMS treatment system for depression, including the world's largest depression outcomes registry. Greenbrook treatment centers also offer SPRAVATO® (esketamine) CIII Nasal Spray, a prescription medicine indicated for the treatment of treatment-resistant depression (TRD) in adults as monotherapy or in conjunction with an oral antidepressant. It is also indicated for depressive symptoms in adults with major depressive disorder (MDD) with acute suicidal ideation or behavior in conjunction with an oral antidepressant.1 Greenbrook has provided more than 1.8 million treatments to over 55,000 patients struggling with depression. The NeuroStar Advanced Therapy System is cleared by the U.S. Food and Drug Administration for adults with MDD, as an adjunct for adults with obsessive-compulsive disorder, to decrease anxiety symptoms in adult patients with MDD that may exhibit comorbid anxiety symptoms (anxious depression), and as a first line adjunct for the treatment of MDD in adolescent patients aged 15-21. For safety information and indications for use, visit Neuronetics Contact:Investors:Mike Vallie or Mark KlausnerICR Healthcare443-213-0499 [email protected]
Newsweek
12-05-2025
- Health
- Newsweek
Nearly 19 Million U.S. Children Live With a Parent With Substance Use Disorder
Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. A staggering 19 million U.S. children were estimated to be living in a household with at least one parent battling a substance use disorder (SUD) in 2023, according to a new study based on data from the National Survey on Drug Use and Health. This figure accounts for nearly one-quarter of all children in the United States, highlighting the prevalence of parental substance abuse among young individuals. The findings also revealed that more than 6.1 million children lived with a parent facing both SUD and a mental illness, such as major depressive disorder or serious psychological distress. The study, published in the journal JAMA Pediatrics, analyzed data from over 62 million parents—and defined SUD according to the criteria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). These criteria include disorders related to alcohol, cannabis, cocaine, prescription drugs and other substances. Mother alcoholic drinks alcohol from a bottle with child is foreground covering ears. Mother alcoholic drinks alcohol from a bottle with child is foreground covering ears. Alexander_Safonov Researchers highlighted the serious risks faced by children exposed to parental SUD. Compared to their peers, these children are more likely to develop a range of adverse outcomes, including early substance use initiation, substance-related problems and mental health disorders. The study provided a detailed breakdown, revealing that 7.6 million children lived with a parent experiencing moderate or severe SUD, while 3.4 million lived with a parent struggling with multiple SUDs. Among parental substance use disorders, alcohol was the most common, followed by cannabis, prescription-related issues and other non-cannabis drug use disorders. Experts emphasized that these findings are a call to action for federal, state and local governments to invest in family-centered interventions. These children are particularly vulnerable to adverse childhood experience, the researchers noted—and without support, they may continue the cycle of substance use and mental health struggles. The study also acknowledged its limitations, including the reliance on self-reported data, suggesting that the actual number of children affected may be even higher. "Additionally, the number of offspring in the household was truncated at three, suggesting that estimates represented the lower bound of youths exposed to parental SUD," the researchers noted. "Direct comparison of the impact of DSM-IV-defined vs DSM-5-defined parental SUD severity is an important step for future research," they wrote. With nearly one in four American children impacted by a parent's substance use disorder, the study's authors are urging greater awareness and support for these families. Evidence-based treatments for both SUD and mental illness, particularly those that include family support, could help mitigate the long-term consequences for these vulnerable children. Do you have a tip on a health story that Newsweek should be covering? Do you have a question about substance use disorder? Let us know via science@ Reference McCabe, S. E., McCabe, V. V., & Schepis, T. S. (2025). US children living with a parent with substance use disorder. JAMA Pediatrics.
NZ Herald
22-04-2025
- Sport
- NZ Herald
Olivia Podmore coronial inquiry: Forensic psychiatrist grilled on Rio Olympian's final message and accusations of ‘weighting' Cycling NZ issues
Podmore died in a suspected suicide the day after the Tokyo Olympics ended, August 9, 2021, after the track cyclist failed to qualify for that event following a Covid-19-interrupted selection process complicated by several controversies. The lawyer representing HPSNZ, Stephanie Grieve KC, narrowed in on comments by Monasterio in the witness stand last November, and in his witness brief, in which she said he placed 'causality' on distressing incidents within Cycling NZ. Grieve said Monasterio did not put equivalent causality on personal factors outside cycling when 'it was not possible to determine precisely' what led to her depressive episodes. One of the 'traumatic' cycling events was in 2016, when Podmore unwittingly exposed an intimate relationship between a CNZ teammate and a coach, after she reported the athlete had not returned home to their hotel after a night out during a training camp in Bordeaux, six weeks out from the Rio Olympics. Podmore was seen as a 'whistleblower' within Cycling NZ following this incident and allegedly subject to intense bullying and marginalisation within the organisation. The other defining disappointment and source of mental distress was Podmore's exclusion from the Tokyo Olympic team. Grieve began by scrutinising Monasterio's interpretation of Podmore's last social media post before her death in which she references the teen abortion 'so that I could follow my Olympic dream'. Podmore referenced a 'cover up' from Cycling NZ and HPSNZ. Grieve argues that Monasterio 'weighted' these cycling incidents over the then 24-year-old's past personal and family issues. 'You refer to the cycling issues, as impacting her, and of course those are clearly present in that post, no dispute about that, but she also refers to not meeting society's expectations, doesn't she, in terms of house, marriage, kids, because she'd given everything to her sport and termination of pregnancy,' Grieve said. 'Friends Thea Lyle and Eric Murray, talked about many things playing on her upbringing, the abortion and separation, the religious school, thinking she was supposed to be married and have children by the time she was 24.' Monasterio said it was evident from that post she felt 'she had sacrificed so much for her sport and that weighed heavy on her'. 'Her words would suggest to me 'I've sacrificed everything to do well in the sport',' he said today. 'And this is a matter for the coroner and the inquiry to determine. I feel that I've been unfairly dealt with. So what I had a sense from that post is that she feels angry and disempowered and feels that she sacrificed so much from her perspective, she's been excluded unfairly.' Monasterio said the extent to which 'not meeting society's expectations' and past relationships are 'interconnected' in Podmore's mental state 'could be subject to some debate'. 'The impression I get is of a young woman who had given so much of her energy and time to succeed at sport. And felt that to some extent she'd been treated unfairly. So she put all her eggs in one basket. And that basket didn't get her to the Olympics. It didn't get her to where she wanted to go. And it seems that that led to despair.' Continuing on the same line of argument, Grieve highlighted that police in summarising witness interviews referred to a number of surrounding circumstances contributing to Podmore's mental deterioration, including the teenage pregnancy, abortion, parental separation, and the cycling high performance issues. 'I'm putting to you that you've... [singled] out the cycling issues but haven't weighted as much the personal issues,' Grieve said. But Monasterio refused to concede to Grieve that it's very hard to rank the stresses and events that influenced Podmore's trials and mental distress. 'Not sure I agree with that… you can weigh to varying degrees the varying factors', Monasterio said. 'Look, all these factors are important. But the timing of events to my mind strongly support the proposition that the Bordeaux incident and the Heron inquiry [in 2018 into the Cycling NZ athlete coach relationship] is very significant,' Monasterio said. 'Then in evidence, I heard that the extent to which Olivia was allegedly bullied and excluded, and in my opinion for a young woman around the ages of 18 and 20 to meet that adversity, that's a very dominant feature. That's why I've weighted it heavily.' Monasterio went on to highlight the contrast with Podmore's mental health in her initial years at the Cambridge High Performance base prior to 2016 were 'actually pretty good'. 'She did really well. She performed well. She went to the junior champs. She got on the podium and that is after her parents' separation and after the abortion. She was described as being gregarious and the kind of person that could light up a room.' 'Remarkably high' depression, anxiety scores Just as he was in November 2024, Monasterio was also asked to give his perspective on the identification of severe to very severe symptoms of depression, anxiety and stress in Podmore via structured psychological screening tools, called the DASS-21, in February 2020 - a time period in which she was attempting to qualify for the Tokyo Games. Monasterio had been critical of the lack of action from health professionals treating Podmore in the 18 months before her death. Advertisement Advertise with NZME. 'Do you think it's sufficient that she's screened this remarkably high result to simply ask 'are you OK?'... [given] this evaluative process you talk about?' Coroner Louella Dunn asked. Monasterio said the 'severe nature of elevated scores' did strike him in his review. 'So there's a real disconnect between what Olivia is identifying, on the screening tool as severe distress, and the information that's being accessed in what seems to be a relatively informal setting,' Monasterio said. 'How you conduct an interview or an assessment is often key to what you find. Now where does this assessment occur? How does it occur? Is it fitted in between training sessions? Is it occurring before or after a sports performance? The scores are very high.' Monasterio said he was not being critical of other clinicians, but that in his opinion, the severity of Podmore's scores would suggest that a formal assessment should have occurred in an environment that would facilitate a reasonable assessment to occur. 'Well, I can't say if I was a clinician because I'm a mental health expert, but if I was faced with this information, I would approach [the athlete]... It's tricky because you're in the middle of a competition... you're about to compete or you've just competed or you're trying to qualify for the Olympics and you've got these extreme scores for depression, anxiety and distress.' But Monasterio said questions should have been asked in a more formalised setting after competition. 'In my opinion, that would be required. These are not mildly elevated scores. These are really, really high scores.' 'There is no dispute' At the outset of the coronial inquest in November 2024 Coroner Dunn said 'there is no dispute' Podmore died by suicide. 'The focus of this inquest will be the mental health challenges Olivia faced and the care she received.' Dunn said the issues the inquest was attempting to answer were:
USA Today
12-04-2025
- Health
- USA Today
What to know about depression symptoms and treatments
What to know about depression symptoms and treatments Show Caption Hide Caption How are SSRIs used to treat depression and anxiety? Antidepressants like SSRIs can be life-saving for people struggling with depression, OCD, anxiety and other mental health conditions. Here's how the work. Everyone feels depressed from time to time. But not everyone has depression. Depression, also referred to as major depressive disorder or clinical depression, is a condition that can cause severe symptoms related to the way you feel, think and go about doing daily activities, according to the National Institutes of Health (NIH). Common symptoms of depression include fatigue, difficulty concentrating, irritability, changes in appetite, sleep disturbances, social withdrawal and physical symptoms including unexplained headaches, digestive problems or other aches and pains, psychiatrist Dr. Judith Joseph tells USA TODAY. If you believe you or a loved one is experiencing depression, here's what mental health experts want you to know. In case you missed: Postpartum depression is more common than many people realize. Here's who it impacts. What causes depression? Depression is an illness that can impact anyone, regardless of age, race, cultural background, education or income, per the NIH. Research has shown evidence that it can be passed on through genetics, but environmental factors also play a role. "People who have trauma or people who are in social settings that are stressful may be at risk for depression or anxiety so it is both nature and nurture," Joseph says. "Not everyone with a family history of depression or anxiety will have these conditions and not all people who have depression or anxiety have a family history of the conditions." Depression affects 1 in 5 people. Here's what it feels like. Does depression go away? For those diagnosed with an anxiety disorder, that disorder won't go away permanently, experts say. But there are many tools that can be used to keep symptoms at bay. "It's important to realize that these are conditions to manage," Joseph says. "Doing daily preventative practices to prevent worsening of depression ... is important." Medical professionals may suggest the following tactics to work to curb depression: Therapy. Different types of counseling or psychotherapy, including cognitive behavioral therapy, dialectical behavioral therapy and motivational therapy, may work for different people. The key, Joseph says, is using the appointments to address underlying issues, including unprocessed trauma and poor coping skills. Different types of counseling or psychotherapy, including cognitive behavioral therapy, dialectical behavioral therapy and motivational therapy, may work for different people. The key, Joseph says, is using the appointments to address underlying issues, including unprocessed trauma and poor coping skills. Medication . Antidepressants usually prescribed for depression, according to NYU Langone Health, include selective serotonin reuptake inhibitors (SSRIs) such as sertraline or citalopram, serotonin-norepinephrine reuptake inhibitors such as venlafaxine and duloxetine and atypical antidepressants including bupropion and mirtazapine. . Antidepressants usually prescribed for depression, according to NYU Langone Health, include selective serotonin reuptake inhibitors (SSRIs) such as sertraline or citalopram, serotonin-norepinephrine reuptake inhibitors such as venlafaxine and duloxetine and atypical antidepressants including bupropion and mirtazapine. Lifestyle modifications. Getting enough sleep, working on stress management techniques, eating a balanced diet and exercising have all been shown to lessen depression symptoms. "Sleep hygiene is important because many of these individuals work late and are on devices late," Joseph says. "They have a hard time calming their minds down and doom scroll." Getting enough sleep, working on stress management techniques, eating a balanced diet and exercising have all been shown to lessen depression symptoms. "Sleep hygiene is important because many of these individuals work late and are on devices late," Joseph says. "They have a hard time calming their minds down and doom scroll." Asking for help. "Strengthening social connections and seeking support from friends, family or support groups is important," Joseph says. Venting to a loved one, therapist, journal or faith leader can help, too. "Strengthening social connections and seeking support from friends, family or support groups is important," Joseph says. Venting to a loved one, therapist, journal or faith leader can help, too. Being honest with yourself. "Acknowledge how you feel and accept your emotions," Joseph says. "Many people push through the day without acknowledging how they feel. They work through lunch when they are hungry, they smile when they are sad and they mask how they are really feeling. If you can't acknowledge and name how you feel, then how can you do anything about it?" If you or someone you know is struggling or in crisis, help is available. Call or text 988 or chat at
CNN
05-02-2025
- Health
- CNN
You'll probably feel better about that problem in the morning, study suggests
Your parents may be right: Get some sleep and you'll feel better in the morning, according to new research. 'Our study suggests that people's mental health and wellbeing could fluctuate over time of day,' said lead study author Dr. Feifei Bu, principal research fellow in statistics and epidemiology at University College London, in an email. 'On average, people seem to feel best early in the day and worst late at night.' To find out how mental health and well-being ebbed and flowed, researchers analyzed University College London data of 49,218 people who were surveyed more than a dozen times between March 2020 and March 2022, according to the study published in the journal BMJ Mental Health. The data showed a trend of people generally reporting better mental health and well-being earlier in the day, with less severe depressive symptoms and increased happiness, life satisfaction and sense of self-worth, Bu said. The limitations of the research It is important to note that while a correlation was found, researchers can't say for sure that the time of day caused people to have better mental health and well-being, Bu added. 'Time of day could affect people's mental health and well-being, but people's mental state could also affect when they choose to respond to the survey,' she said. 'While our findings are intriguing, they need to be replicated in other studies that fully address this possibility.' And mental health and well-being may need to be looked at separately, said Dr. Pamela Rutledge, director of the Media Psychology Research Center and professor emerita of media psychology at Fielding Graduate University in Santa Barbara, California. 'Mental health and well-being are two overlapping but distinct constructs. Mental health is a crucial part of well-being, but well-being is more than just mental health,' she said. Well-being is a positive state determined by social, economic and environmental conditions that includes quality of life and a sense of meaning and purpose, according to the World Health Organization. It makes sense that mental health and well-being are at the focus of this study, as previous studies looked mostly at associations with mood, Rutledge said. 'Mood is a temporary affective state, while mental health and well-being are broader and more stable conditions that include emotional, psychological, and cognitive appraisals,' she added. When resources are available Knowing how mental health and well-being fluctuate may give new insight into how resources should be made available. 'Mental health support services may consider adjusting resources to match fluctuating needs across the day — for instance, prioritising late-night availability,' Bu said in an email. This latest study confirms what previous research has already found: 'The demand for interventions and care, especially among young people, rises in the evening and seasonally, influenced by temperature, day length, and cultural, regional and individual differences,' Rutledge added. Confront hard things when its best for you Does the research show it's better to just go to bed and handle emotionally difficult things in the morning, then? The research is conflicting, but most evidence points to late morning as the best time for that kind of problem solving, Rutledge said. 'Research suggests that mood is relatively stable in the late morning, which makes it easier to handle tough topics with a level head and emotional distance,' she added. Midafternoon is when levels of cortisol, the stress hormone, may be lower, but that decrease is countered by research that shows that mood dips and decision fatigue sets in around that time of day, Rutledge said. 'The early evening may be best for personal emotional processing, such as journaling and reflection, once emotional balance is regained. It may also be a good time for empathetic listening rather than having those tough conversations,' she said. While there are physiological changes throughout the day that may influence how you handle things, there are bigger correlations between mental health and well-being and time of year, according to Rutledge. What's more, stress, autonomy, social support and environmental conditions all have an impact on mood as well, she added. And if you aren't a morning person, this research doesn't have to mean you should rearrange your life, Bu said. 'Your personal experience may vary,' she said. 'If you are a night owl who feels (in) top form at midnight, don't panic.'
